Central Garden & Pet Company announced that it has appointed Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026. Ms. Schwichtenberg brings more than 40 years of experience in the animal health industry, including 29 years with Central. Most recently, she served as Central?s Executive Vice President, Animal & Public Health, a role she held until her retirement from the company in February 2023.

Prior to that position, which she assumed in April 2014, Ms. Schwichtenberg held several senior leadership positions at Central, including Special Projects Advisor, President & CEO of Central Life Sciences, and President of Wellmark International. Ms. Schwichtenberg joined Central in 1997 through the acquisition of the Consumer and Animal Health Division from Sandoz Inc. (now Novartis Inc.), a global pharmaceutical company, where she served as Vice President and General Manager. Earlier in her career, she held a variety of sales and marketing roles at Brunswick Corporation and Market Facts Inc. Ms. Schwichtenberg is an elected Life Director of the University of Illinois Foundation Board, where she served as a Chair, and a past chair of the American Pet Products Association (APPA).

She completed the Advanced Executive Program at London Business School and is a member of the International Women?s Forum. She earned a Master of Business Administration from the University of Illinois at Chicago.